News

World leaders in academia and industry share their latest advances in bioengineering, discuss current trends in innovation, and network with their peers

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) hosted their second annual Terasaki Innovation Summit on March 27-29, 2024, at the UCLA Meyer & Renee Luskin Center in Los Angeles. This year’s program focused on future directions in human and planetary health, as well as the latest trends in biomedical innovation and translation.

Read more ...

JACKSONVILLE, Fla. — Mayo Clinic and Terasaki Institute for Biomedical Innovation announced today a research collaboration centered on improving organ transplant outcomes.

Beginning in April, Mayo Clinic biomedical researchers and Terasaki Institute scientists will work together on two core areas: real-time monitoring of donated organ health from procurement to transplant surgery and developing predictive technologies to determine which transplant recipients have a higher likelihood of rejection. That will be done by creating prognostic signatures and assays for antibody-mediated rejection of organ transplant. These initial projects are expected to take 24 to 30 months to complete.

Read more ...

(LOS ANGELES) –In a landmark move for biomedical progress, the Terasaki Institute for Biomedical Innovation (TIBI) today unveiled the launch of four pioneering startup companies. These ventures represent a strategic leap forward in TIBI's commitment to transforming healthcare through innovation. By harnessing the institute's groundbreaking research in biomaterials, micro-needles, organoids, tissue engineering, and advanced biosensing, these startups are poised to tackle some of the most pressing health challenges of our time.

Read more ...

New hydrogel features enhanced capabilities for treating aneurysms and halting their progression

(LOS ANGELES) – A novel, injectable shear-thinning hydrogel for treating abdominal aortic aneurysms (AAA) has been developed by scientists at the Terasaki Institute for Biomedical Innovation (TIBI). This hydrogel not only demonstrates increased effectiveness at sealing off blood flow to AAAs, but also stops the growth of the aneurysms themselves.

Read more ...

(LOS ANGELES) –The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce their selection of Professor Nicholas A. Peppas of The University of Texas at Austin as the recipient of the 2024 Paul Terasaki Distinguished Scientist Innovation Award. The award will be presented at TIBI’s 2^nd annual Terasaki Innovation Summit, to be held March 27-29, 2024, at the UCLA Meyer & Renee Luskin Conference Center.

Read more ...

(LOS ANGELES) – The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce their selection of Assistant Professors Amir Manbachi of Johns Hopkins University and Ritu Raman of the Massachusetts Institute of Technology (MIT) as the recipients of the 2024 Hisako Terasaki Young Innovator Awards. The awards will be presented at TIBI’s 2^nd annual Terasaki Innovation Summit, to be held March 27-29, 2024, at the UCLA Meyer & Renee Luskin Conference Center.

Read more ...

(LOS ANGELES) – Vadim Jucaud, Ph.D., Assistant Professor at the Terasaki Institute for Biomedical Innovation, has been awarded a grant from the National Institutes of Health to develop a functional organ-on-a-chip to model allogeneic transplant rejection. Such a model would allow the study of allograft tolerance and may ultimately lead to reducing organ transplant rejections without needing immunosuppressive drugs. 

Read more ...

The new year opened with a bang for the Terasaki Institute for Biomedical Innovation (TIBI), with the long-awaited completion of TIBI’s brand-new 50,000 square foot facility in Woodland Hills. TIBI scientists and staff made the big move to the new building at the end of February 2023.

In addition to the ample space and unique design features of the new building, the facility houses expansive laboratory work areas, fully arrayed with scientific equipment, as well as accommodations for meetings and seminars. This will allow for greater research capabilities and growth of the institute.

Read more ...